Mouse models of neurofibromatosis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1471, Issue 2, 2001, Pages

  McClatchey, Andrea I ^a   Cichowski, Karen ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Malignant peripheral; Mouse; Nerve sheath tumor; Neurofibromatosis

Indexed keywords

ANIMAL MODEL; CANCER MODEL; FAMILIAL CANCER; GENETIC LINKAGE; HETEROZYGOSITY LOSS; NERVE SHEATH TUMOR; NEURINOMA; NEUROFIBROMATOSIS; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALIA;

EID: 0035951463     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(00)00026-3     Document Type: Review

References (31)

1. The neurofibromatoses
2. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
3. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
4. Mouse models of tumor development in neurofibromatosis type 1
5. Multiple cell origin of hereditary neurofibromas
6. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein
7. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2
8. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides
9. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
10. Tumor suppressor gene mutations in mice
11. Antioncogenes and human cancer
12. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia
13. In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells
14. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation
15. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors
16. Tumor suppressor mutations in mice: The next generation
17. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice
18. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
19. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
20. A mouse model for the learning and memory deficits associated with neurofibromatosis type I
21. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
22. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
23. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
24. Mouse tumor model for neurofibromatosis type 1
25. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients
26. The neurofibromatosis type 1 gene encodes a protein related to GAP
27. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis
28. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells
29. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin)
30. Allelic loss of the NF1 gene in Nf1-associated plexiform neurofibromas